SEC Form 4 · accession 0001225208-15-019763
Cigna Holding Co · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert A Fritch
Officer — President, HealthSpring
Period of report
Oct 15, 2015
Accepted (ET)
Oct 19, 2015 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000701221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.25 Par Value | Oct 15, 2015 | M | 27,482 | $30.13 | A | 310,607 | D | |
| Common Stock, $.25 Par ValueF2 | Oct 15, 2015 | S | 2,000 | $134.781 | D | 308,607 | D | |
| Common Stock, $.25 Par ValueF3 | Oct 15, 2015 | S | 2,793 | $138.4707 | D | 305,814 | D | |
| Common Stock, $.25 Par ValueF4 | Oct 15, 2015 | S | 6,101 | $138.0844 | D | 299,713 | D | |
| Common Stock, $.25 Par ValueF5 | Oct 15, 2015 | S | 13,800 | $135.8071 | D | 285,913 | D | |
| Common Stock, $.25 Par ValueF6 | Oct 15, 2015 | S | 14,508 | $136.7755 | D | 271,405 | D | |
| Common Stock, $.25 Par Value | Oct 16, 2015 | M | 7,908 | $30.13 | A | 279,313 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F7 | $30.13 | Oct 15, 2015 | M | 27,482 | D | — | Mar 7, 2021 | Common Stock, $.25 Par Value | 27,482 | 101,296 | D |
| Employee Stock Option (Right to Buy)F7 | $30.13 | Oct 16, 2015 | M | 7,908 | D | — | Mar 7, 2021 | Common Stock, $.25 Par Value | 7,908 | 93,388 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- F2Represents the weighted average price of the shares sold. The prices actually received ranged from $134.22 to $135.17 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F3Represents the weighted average price of the shares sold. The prices actually received ranged from $138.38 to $138.56 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F4Represents the weighted average price of the shares sold. The prices actually received ranged from $137.38 to $138.35 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F5Represents the weighted average price of the shares sold. The prices actually received ranged from $135.24 to $136.22 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F6Represents the weighted average price of the shares sold. The prices actually received ranged from $136.31 to $137.23 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F7This option vested as follows: 50% on March 7, 2013, 25% on March 7, 2014 and 25% on March 7, 2015.